A Study to Learn About the Study Medicine Called Tafamidis 61mg in People Diagnosed With Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
NCT06321523
·
clinicaltrials.gov ↗
COMPLETED
Status
13
Enrollment
INDUSTRY
Sponsor class
Conditions
Transthyretin Amyloid Cardiomyopathy
Interventions
DRUG:
Tafamidis 61 milligrams
Sponsor
Pfizer